Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment…

Overview of attention for article published in BMC Urology, June 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 17 Mendeley

So far, Altmetric has seen 1 X post from an account with 1,025 followers.

Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures https://t.co/ea18fN5uDT via @BioMedCentral #OpenAc

21 Jun 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.